NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-056-2007-0-IE-12 Apparatus For Microarray Binding Sensors Having Biological Probe Materials Using Carbon Nanotube Transistors IE EP 07753436.0 Abandoned
NCI E-008-2008-0-AU-03 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ESPHAGEAL ADENOCARCINOMAS AU National Stage 2008310704 Abandoned
NCI E-008-2008-0-CN-05 MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status CN National Stage 200880116343.7 Abandoned
NCI E-080-2006-0-US-06 TETRAHALOGENATED COMPOUNDS USEFUL AS INHIBITORS OF ANGIOGENESIS US National Stage 12/287,597 8143252 Abandoned PDF
NIDCR E-001-2008-0-US-02 Micropatterning Of Biological Molecules Using Laser Ablation US ORD 12/249,824 8048641 Issued PDF
NIAAA E-211-2006-0-PCT-02 Therapeutic Applications Of Fatty Acid Amide Hydrolase Inhibitors PCT PCT PCT/US2008/011657 Expired
NCI E-008-2008-0-PCT-02 MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status PCT PCT PCT/US2008/079482 Expired
NIAID E-255-2000-0-US-04 Antibodies and Other Ligands Directed Against KIR2DL4 Receptor For Production of Interferon Gamma US CON 12/249,703 Abandoned
NIAAA E-211-2006-0-EP-08 Therapeutic Applications Of Fatty Acid Amide Hydrolase Inhibitors EP DIV 13191954.0 Abandoned
NCI E-008-2008-0-EP-08 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ESPHAGEAL ADENOCARCINOMAS EP National Stage 08838376.5 Abandoned
NIAAA E-211-2006-0-EP-05 Therapeutic Applications Of Fatty Acid Amide Hydrolase Inhibitors EP National Stage 08840095.7 Abandoned
NCI E-008-2008-0-JP-06 MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status JP National Stage 2010-529072 Abandoned
NCI E-008-2008-0-CA-04 MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status CA National Stage 2702241 Abandoned
NIAAA E-211-2006-0-CA-04 Therapeutic Applications Of Fatty Acid Amide Hydrolase Inhibitors CA National Stage 2702468 Abandoned
NIAAA E-211-2006-0-AU-03 THERAPEUTIC APPLICATIONS OF FATTY ACID AMIDE HYDROLASE INHIBITORS AU National Stage 2008312002 Abandoned
NIAID E-003-2009-0-US-01 Use Of Mosiac Envelope Proteins To Optimize T Cell Responses Against HIV Envelope US 61/195,845 Abandoned
NCI E-103-2006-2-US-02 Methods And Compositions For The Identification Of Genetic Signatures Of Heterozygous Carriers Of Mutant Suppressor Genes And Methods Of Use Thereof US National Stage 12/096,685 Abandoned
NCATS E-326-2008-0-US-01 Activators of Human Pyruvate Kinase US 61/104,091 Abandoned
NCI E-037-2001-1-JP-10 Method And Composition for Enhancing an Immune Response JP DIV 2008-262301 Abandoned
NCI E-336-2005-0-US-07 Antibody Compositions and Methods for Treatment of Neoplastic Disease US National Stage 12/296,328 8071323 Abandoned PDF
NCI E-336-2005-0-BR-08 ANTIBODY COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE BR National Stage PI0709481-7 Abandoned
NICHD E-186-2008-0-PCT-01 Freeze-Dried Copper Histidine Enhances Survival In Infants With Menkes Disease PCT PCT PCT/US2008/078966 Abandoned
NICHD E-282-2003-0-US-09 Clinical Predictive Genetic Test For Venous Thrombosis US CON 12/245,627 Abandoned
NCI E-010-2008-0-US-01 METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY US 61/195,084 Abandoned
NCI E-282-2008-0-US-01 GENE EXPRESSION SIGNATURE PREDICTIVE RESPONSE TO CHEMOTHERAPY US 61/195,123 Abandoned
NIAID E-005-2009-0-US-01 Flavivirus-Based System for Production of Hepatitis C Virus (HCV) US 61/195,088 Abandoned
NICHD E-339-2008-0-US-01 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. US 61/101,944 Abandoned
NCI E-051-2009-0-JP-01 Large Scale Cell Lysate Sample Collection For Cell Signaling Analysis JP ORD 2008-254746 Abandoned
NIAID E-130-2002-0-JP-11 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE JP DIV 2008-251982 Abandoned
NIAID E-189-2008-1-US-01 Leishmania Vaccine Using Sand Fly Salivary Immunogen US 61/101,345 Abandoned
NCI E-097-2006-1-US-01 TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT US CIP 12/241,011 8865686 Abandoned PDF
NINDS E-251-2005-1-US-03 DEVICE FOR VOLITIONAL SWALLOWING WITH A SUBSTITUTE SENSORY SYSTEM US ORD 12/240,398 8449445 Issued PDF
NCI E-294-2002-0-US-08 Target for Anti-Angiogenesis Therapy US DIV 12/240,656 7862815 Abandoned PDF
NLM E-107-2010-0-US-02 CONVERSION OF 5-METHYLCYTOSINE TO 5-HYDROXYMETHYLCYTOSINE IN Mammalian DNA By MLL Partner TET1 US 61/100,995 Abandoned
NHLBI E-145-2010-2-EP-03 Methods And Compositions For Modulating BCL-2 Family Polypeptides EP National Stage 08834506.1 Issued
NHLBI E-145-2010-2-CH-06 Methods And Compositions For Modulating BCL-2 Family Polypeptides CH EP 08834506.1 Issued
NHLBI E-145-2010-2-GB-09 Methods And Compositions For Modulating BCL-2 Family Polypeptides GB EP 08834506.1 Issued
NHLBI E-145-2010-2-DE-07 Methods And Compositions For Modulating BCL-2 Family Polypeptides DE EP 08834506.1 Issued
NHLBI E-145-2010-2-FR-08 Methods And Compositions For Modulating BCL-2 Family Polypeptides FR EP 08834506.1 Issued
NHLBI E-145-2010-2-JP-04 Methods And Compositions For Modulating BCL-2 Family Polypeptides JP National Stage 2010-526974 Issued
NHLBI E-145-2010-2-US-05 Methods And Compositions For Modulating BCL-2 Family Polypeptides US National Stage 12/680,098 8921323 Issued PDF
NINDS E-187-2007-0-EP-06 Isoindoline Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses EP National Stage 08833236.6 Abandoned
NINDS E-187-2007-0-PCT-02 Isoindoline Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses PCT PCT PCT/US2008/077936 Expired
NHLBI E-145-2010-2-PCT-01 Methods And Compositions For Modulating BCL-2 Family Polypeptides PCT PCT COMB PCT/US2008/011500 Expired
NCI E-177-2003-0-US-03 Boosting Thymus Function By Inhibiting The Function Of The Gene, SPATIAL, Its Products, Or The Pathways By Which It Regulates Thymic Functions US CON 12/239,466 Abandoned
NCI E-042-1998-0-US-06 cDNA For A Human Gene Deleted in Liver Cancer US DIV 12/239,581 Abandoned
NCI E-165-2006-0-US-04 Diamidine Inhibitors of TDP1 US National Stage 12/225,672 Abandoned
NINDS E-187-2007-0-EP-07 Isoindoline Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses EP DIV 12198010.6 Abandoned
NLM E-107-2010-0-US-01 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS US 61/100,503 Abandoned
NIAID E-341-2008-0-US-01 DNA PRIME/INACTIVATED VACCINE BOOST IMMUNIZATION TO INFLUENZA VIRUS US 61/100,621 Abandoned